Literature DB >> 21254334

Forced involution of the functionally differentiated mammary gland by overexpression of the pro-apoptotic protein bax.

Edmund B Rucker1, Amber N Hale, David C Durtschi, Kazuhito Sakamoto, Kay-Uwe Wagner.   

Abstract

The mammary gland is a developmentally dynamic, hormone-responsive organ that undergoes proliferation and differentiation within the secretory epithelial compartment during pregnancy. The epithelia are maintained by pro-survival signals (e.g., Stat5, Akt1) during lactation, but undergo apoptosis during involution through inactivation of cell survival pathways and upregulation of pro-apoptotic proteins. To assess if the survival signals in the functionally differentiated mammary epithelial cells can override a pro-apoptotic signal, we generated transgenic mice that express Bax under the whey acidic protein (WAP) promoter. WAP-Bax females exhibited a lactation defect and were unable to nourish their offspring. Mammary glands demonstrated: (1) a reduction in epithelial content, (2) hallmark signs of mitochondria-mediated cell death, (3) an increase in apoptotic cells by TUNEL assay, and (4) precocious Stat3 activation. This suggests that upregulation of a single pro-apoptotic factor of the Bcl-2 family is sufficient to initiate apoptosis of functionally differentiated mammary epithelial cells in vivo.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254334      PMCID: PMC3703757          DOI: 10.1002/dvg.20691

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  51 in total

1.  Differential activation of STATs 3 and 5 during mammary gland development.

Authors:  J A Philp; T G Burdon; C J Watson
Journal:  FEBS Lett       Date:  1996-10-28       Impact factor: 4.124

2.  Human ICE/CED-3 protease nomenclature.

Authors:  E S Alnemri; D J Livingston; D W Nicholson; G Salvesen; N A Thornberry; W W Wong; J Yuan
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

3.  Modulation of clusterin gene expression in the rat mammary gland during pregnancy, lactation, and involution.

Authors:  L E French; J V Soriano; R Montesano; M S Pepper
Journal:  Biol Reprod       Date:  1996-12       Impact factor: 4.285

4.  Overexpression of an Agouti cDNA in the skin of transgenic mice recapitulates dominant coat color phenotypes of spontaneous mutants.

Authors:  G T Kucera; D M Bortner; M P Rosenberg
Journal:  Dev Biol       Date:  1996-01-10       Impact factor: 3.582

5.  Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.

Authors:  E Yang; J Zha; J Jockel; L H Boise; C B Thompson; S J Korsmeyer
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

6.  Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells.

Authors:  K Heermeier; M Benedict; M Li; P Furth; G Nuñez; L Hennighausen
Journal:  Mech Dev       Date:  1996-05       Impact factor: 1.882

7.  Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model.

Authors:  S Neuenschwander; A Schwartz; T L Wood; C T Roberts; L Hennighausen; D LeRoith
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

8.  Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells.

Authors:  A Marti; B Jehn; E Costello; N Keon; G Ke; F Martin; R Jaggi
Journal:  Oncogene       Date:  1994-04       Impact factor: 9.867

9.  Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland.

Authors:  Z Feng; A Marti; B Jehn; H J Altermatt; G Chicaiza; R Jaggi
Journal:  J Cell Biol       Date:  1995-11       Impact factor: 10.539

10.  Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways.

Authors:  L R Lund; J Rømer; N Thomasset; H Solberg; C Pyke; M J Bissell; K Danø; Z Werb
Journal:  Development       Date:  1996-01       Impact factor: 6.868

View more
  6 in total

Review 1.  Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.

Authors:  D Merino; S W Lok; J E Visvader; G J Lindeman
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

2.  Marginal maternal zinc deficiency in lactating mice reduces secretory capacity and alters milk composition.

Authors:  Colleen Dempsey; Nicholas H McCormick; Thomas P Croxford; Young Ah Seo; Arthur Grider; Shannon L Kelleher
Journal:  J Nutr       Date:  2012-02-22       Impact factor: 4.798

Review 3.  Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?

Authors:  Michelle M Williams; Rebecca S Cook
Journal:  Oncotarget       Date:  2015-02-28

4.  miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy.

Authors:  Ruth Rodriguez-Barrueco; Erin A Nekritz; François Bertucci; Jiyang Yu; Felix Sanchez-Garcia; Tizita Z Zeleke; Andrej Gorbatenko; Daniel Birnbaum; Elena Ezhkova; Carlos Cordon-Cardo; Pascal Finetti; David Llobet-Navas; Jose M Silva
Journal:  Genes Dev       Date:  2017-03-15       Impact factor: 11.361

5.  Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamics.

Authors:  Joaquin Chapa; Ryan J Bourgo; Geoffrey L Greene; Swati Kulkarni; Gary An
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

6.  Autophagy and unfolded protein response (UPR) regulate mammary gland involution by restraining apoptosis-driven irreversible changes.

Authors:  Anni Wärri; Katherine L Cook; Rong Hu; Lu Jin; Alan Zwart; David R Soto-Pantoja; Jie Liu; Toren Finkel; Robert Clarke
Journal:  Cell Death Discov       Date:  2018-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.